Watson Pharmaceuticals Inc appoints Robert A. Stewart as senior VP of global operations
WPI | Quote | Chart | News | PowerRating -- Speciality pharmaceutical company Watson Pharmaceuticals Inc (NYSE:WPI)
reported on Monday the appointment of Robert A. Stewart as senior vice
president of global operations with immediate effect.
A
This is a newly created position in which Stewart will oversee global
manufacturing, supply chain, quality and technical operations of the
company.
A
Previously Stewart spent eight years at Abbott Laboratories, where he
most recently served as divisional vice president, global supply chain.
A
In conjunction, the company announced that Thomas R. Russillo,
executive vice president and president of the generics division, has
been named executive vice president, global generics.
A
Russillo will head the company's newly formed Global Generics
commercial function.
A
Stewart and Russillo will both report to Paul Bisaro, president and CEO
of the company.
Comments on this story may be sent to admin@m2.com
For full details on Watson Pharmaceuticals (WPI) WPI. Watson Pharmaceuticals (WPI) has Short Term PowerRatings at TradingMarkets. Details on Watson Pharmaceuticals (WPI) Short Term PowerRatings is available at This Link.
- Watson and HRA Pharma sign licensing agreement - 02/03/10
- Watson Pharmaceuticals signs licensing agreement with HRA Pharma for ulipristal acetate (UPA) - 02/02/10
- Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook - 02/02/10
- Watson Pharmaceuticals completes acquisition of Eden Biodesign - 02/01/10
- Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S. - 02/01/10
- More News >>


